New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 14, 2014
18:15 EDTTSO, APOL, MPC, VLO, SAVE, HFC, NURO, PPHMOn The Fly: After Hours Movers
UP AFTER EARNINGS: Peregrine Pharmaceuticals (PPHM), up 2.3% after reports fourth quarter results. ALSO HIGHER: Spirit Airlines (SAVE), up 1.5% after Lone Pine Capital reported a 6% passive stake. LOWER: Apollo Education (APOL), down 6.2% following an announcement that the Department of Education intends to conduct an ordinary course program review of University of Phoenix... Neurometrix (NURO), down just under 1% after the company files to sell 5.89M shares of common stock for holders. NOTABLE: Valero Energy (VLO), down 3.4% after announcing second quarter guidance below analyst estimates... Tesoro (TSO), down almost 1%, HollyFrontier (HFC), down marginally, and Marathon Petroleum (MPC), down fractionally, are also lower following Valero Energy's announcement.
News For PPHM;SAVE;APOL;NURO;VLO;TSO;HFC;MPC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 20, 2015
15:43 EDTSAVEAirlines fall as analysts grapple with concerns over capacity growth
Subscribe for More Information
12:44 EDTSAVESpirit Airlines volatility flat on wide price movement
Spirit Airlines June call option implied volatility is at 31, July is at 32 compared to its 90-day average of 33, suggesting non-directional price movement on concerns of worsening competitive backdrop and lean competitors vowing to compete aggressively.
11:56 EDTSAVESterne Agee CRT recommends aggressively adding to airline positions
Subscribe for More Information
10:01 EDTSAVEOptions with increasing volume: DAL LUV AAL UAL SAVE ALK JBLU
May 19, 2015
13:34 EDTMPCU.S. settles with Marathon Petroleum over air emissions
Subscribe for More Information
May 18, 2015
09:46 EDTMPCMPLX enters common unit sales agreement for up to $500M
Subscribe for More Information
May 15, 2015
06:01 EDTVLOValero remains a top pick at Goldman
Subscribe for More Information
May 13, 2015
17:19 EDTPPHMPeregrine to highlight Bavituximab at ASCO annual meeting
Peregrine Pharmaceuticals, a biopharmaceutical company focused on advancing bavituximab, a novel immuno-oncology agent in Phase III development, announced the presentation of three posters at the 2015 American Society of Clinical Oncology, ASCO, Annual Meeting, to be held May 29-June 2 in Chicago, Illinois.
16:43 EDTHFCHollyFrontier raises quarterly dividend 1c to 33c per share
HollyFrontier announced that its board of directors approved an increase in the company's regular quarterly dividend to 33c per share from the previous rate of 32c per share. The dividend will be paid on June 26 to holders of record of common stock on June 5. "We intend to maintain both a competitive dividend yield and total cash yield relative to our peer group," said the company.
13:05 EDTNURONeuroMetrix announces first shipments of Quell wearable pain relief device
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use